Risks of an adverse event following influenza vaccination are far less common than complications related to influenza itself, and the adverse events are generally localised and mild.
The EVD-LabNet is strengthening capacity for early detection and surveillance of (re)emerging viral diseases in the EU/EEA countries and EU Candidate Countries.
Seasonal influenza is a vaccine-preventable disease and annual influenza vaccination is the most effective way to prevent influenza. ECDC continues to emphasise that all Europeans who are recommended to have the influenza vaccine should get vaccinated.
The Emerging and Vector-borne Diseases (EVD) team of ECDC communicates, consults and cooperates with EVD-Net on surveillance, response, prevention, control and preparedness aspects of EVDs and vectors, with particular focus on country needs and country support possibilities.